Skip to content
Riskpilot
← Back to search
Sign in
Get full access
FranzPharma Ab
OY
Active
Y-tunnus 2962142-5
Lilluddsstigen 38, 21670
Pärnäinen
Retail sale of other food
· NACE 4727
Est. 2018 · 7 years old
— employees
Share
Finland
/
Companies
/
Retail sale of other food
/
FranzPharma Ab
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
EUR millions
0M
0M
1M
1M
1M
1M
2021
1M
2022
1M
2023
1M
2024
1M
2025
EBITDA
EUR millions
0M
-0M
-1M
-1M
-1M
0M
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
0M
0%
2025
Income statement
EUR thousands
Item
2021
2022
2023
2024
2025
Revenue
615
1 093
1 003
1 014
1 032
Staff expenses
—
—
−0
−0
−0
EBITDA
160
287
287
328
346
Depreciation & amort.
—
—
−0
−0
−0
EBIT
160
287
287
328
346
Net financials
−0
—
−0
−0
−0
Profit before tax
160
287
287
328
346
Tax
32
57
57
66
69
Net profit
128
230
229
262
277
Balance sheet
EUR thousands
Item
2021
2022
2023
2024
2025
Total assets
152
521
0
895
1 089
Equity
137
463
655
865
1 073
Long-term debt
—
—
0
0
0
Short-term debt
16
58
64
30
17
Total debt
16
58
64
30
17
Financial ratios
5-year trend
EBITDA margin
33.5%
This company
15.8%
Market median
+112% vs market
2021
2025
Equity ratio
98.5%
This company
38.2%
Market median
+158% vs market
2021
2025
Return on equity
25.8%
This company
18.4%
Market median
+40% vs market
2021
2025
Net profit margin
26.8%
This company
8.1%
Market median
+231% vs market
2021
2025
Asset turnover
0.95×
This company
1.12×
Market median
+15% vs market
2021
2025
Debt / equity
0.02×
This company
0.62×
Market median
+97% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via PRH / YTJ · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
View
PDF
More on FranzPharma Ab
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network